|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Cash flows from Operating Activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| Interest earned on marketable securities held in Trust Account | |
| Unrealized gain on change in fair value of warrants | |
| Unrealized gain on change in fair value of over-allotment liability | |
| Amortization of prepaid expenses | |
| Transaction costs allocated to warrant liabilities | |
| Changes in current assets and current liabilities: | |
| Prepaid expenses | |
| Accrued offering costs and expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Marketable securities held in Trust Account | |
| Net cash used in investing activities | |
| Cash flows from Financing Activities: | |
| Proceeds from Initial Public Offering, net of underwriters’ fees | |
| Proceeds from private placement | |
| Repayment to promissory note to related party | |
| Payments of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash, end of the period | |
| Supplemental disclosure of noncash investing and financing activities: | |
| Deferred underwriting commissions charged to additional paid in capital | |
| Remeasurement of Class A ordinary shares to redemption value | |
| Deferred offering costs paid by Sponsor loan | |
| Initial classification of warrant liabilities | |
| Initial classification of over-allotment liability | |
| Full exercise of over-allotment option |
Loading...
